https://www.vetsurgeon.org/w/veterinary-research/70/treatment-of-bacterial-folliculitis-abscesses-and-wounds-with-cefovecinIn this wiki, members may publish case studies and reports, presentations, short communications, research papers and the results of clinical audits relating to small animals, for open review / discussion by all members of VetSurgeon.en-USTelligent Community 10https://www.vetsurgeon.org/w/veterinary-research/70/treatment-of-bacterial-folliculitis-abscesses-and-wounds-with-cefovecinThu, 08 Oct 2009 17:06:02 GMT146601cc-3922-4be7-9974-7e1d4e45a66b:cca41d7a-08f7-44f0-bec4-205036af8290Arlo Guthriehttps://www.vetsurgeon.org/w/veterinary-research/70/treatment-of-bacterial-folliculitis-abscesses-and-wounds-with-cefovecin#commentsCurrent Revision posted to Abstracts, Short Communications &amp; Research by Arlo Guthrie on 10/8/2009 5:06:02 PM<br /> <h3 align="left">Robert Six and others, Pfizer Animal Health, Kalamazoo</h3> <p align="left">Cefovecin is a third generation, extended spectrum cephalosporin developed for the treatment of bacterial infections in dogs and cats. The authors describe studies evaluating the safety and efficacy of the product in the treatment of naturally occurring secondary superficial pyoderma, abscesses and infected wounds in dogs. In 235 animals, a single 8mg/kg subcutaneous injection of cefovecin, repeated at 14-day intervals, was safe and as effective against these conditions as twice daily oral dosing with cefadroxil.</p> <p align="left"><em><a target='_blank' href="http://avmajournals.avma.org/loi/javma">Journal of the American Veterinary Medical Association 233 (3): 433-439</a>.</em></p> <p> <p align="left">Abstract reproduced by kind permission of <em>Veterinary Practice</em> magazine</p> </p> <p align="left"><img src="/resized-image.ashx/__size/550x0/__key/CommunityServer.Wikis.Components.Files/veterinary-research/2605.abstracts_2D00_logo.gif" border="0" alt="" /></p><div style="clear:both;"></div> <div style="font-size: 90%;">Tags: folliculitis, Dogs, Dermatology</div> https://www.vetsurgeon.org/w/veterinary-research/70/treatment-of-bacterial-folliculitis-abscesses-and-wounds-with-cefovecin/revision/2Wed, 17 Jun 2009 16:47:23 GMT146601cc-3922-4be7-9974-7e1d4e45a66b:cca41d7a-08f7-44f0-bec4-205036af8290Arlo Guthriehttps://www.vetsurgeon.org/w/veterinary-research/70/treatment-of-bacterial-folliculitis-abscesses-and-wounds-with-cefovecin#commentsRevision 2 posted to Abstracts, Short Communications &amp; Research by Arlo Guthrie on 6/17/2009 4:47:23 PM<br /> <h3 align="left">Robert Six and others, Pfizer Animal Health, Kalamazoo</h3> <p align="left">Cefovecin is a third generation, extended spectrum cephalosporin developed for the treatment of bacterial infections in dogs and cats. The authors describe studies evaluating the safety and efficacy of the product in the treatment of naturally occurring secondary superficial pyoderma, abscesses and infected wounds in dogs. In 235 animals, a single 8mg/kg subcutaneous injection of cefovecin, repeated at 14-day intervals, was safe and as effective against these conditions as twice daily oral dosing with cefadroxil.</p> <p align="left"><em><a target='_blank' href="http://avmajournals.avma.org/loi/javma">Journal of the American Veterinary Medical Association 233 (3): 433-439</a>.</em></p> <p> <p align="left">Abstract reproduced by kind permission of <em>Veterinary Practice</em> magazine</p> </p> <p align="left"><img border="0" src="/resized-image.ashx/__size/550x0/__key/CommunityServer.Wikis.Components.Files/veterinary-research/2605.abstracts_2D00_logo.gif" alt="" /></p><div style="clear:both;"></div> <div style="font-size: 90%;">Tags: dogs, dermatology, folliculitis</div> https://www.vetsurgeon.org/w/veterinary-research/70/treatment-of-bacterial-folliculitis-abscesses-and-wounds-with-cefovecin/revision/1Wed, 17 Jun 2009 16:46:52 GMT146601cc-3922-4be7-9974-7e1d4e45a66b:cca41d7a-08f7-44f0-bec4-205036af8290Arlo Guthriehttps://www.vetsurgeon.org/w/veterinary-research/70/treatment-of-bacterial-folliculitis-abscesses-and-wounds-with-cefovecin#commentsRevision 1 posted to Abstracts, Short Communications &amp; Research by Arlo Guthrie on 6/17/2009 4:46:52 PM<br /> <h3 align="left">Robert Six and others, Pfizer Animal Health, Kalamazoo</h3> <p align="left">Cefovecin is a third generation, extended spectrum cephalosporin developed for the treatment of bacterial infections in dogs and cats. The authors describe studies evaluating the safety and efficacy of the product in the treatment of naturally occurring secondary superficial pyoderma, abscesses and infected wounds in dogs. In 235 animals, a single 8mg/kg subcutaneous injection of cefovecin, repeated at 14-day intervals, was safe and as effective against these conditions as twice daily oral dosing with cefadroxil.</p> <p align="left"><em><a target='_blank' href="http://avmajournals.avma.org/loi/javma">Journal of the American Veterinary Medical Association 233 (3): 433-439</a>.</em></p> <p> <p align="left">Abstract reproduced by kind permission of <em>Veterinary Practice</em> magazine</p> </p> <p align="left"><img border="0" src="/resized-image.ashx/__size/550x0/__key/CommunityServer.Wikis.Components.Files/veterinary-research/2605.abstracts_2D00_logo.gif" alt="" /></p><div style="clear:both;"></div> <div style="font-size: 90%;">Tags: dogs, dermatology</div>